Barrett's adenocarcinoma indicates higher incidences of hypermethylation in the E-cadherin, human MutL homolog 1, p16/INK4A and O6-methylguanine-DNA methyltransferase than BE [16]. This evidence concerns the gene CDKN2A and Barrett adenocarcinoma.